Konidaris Tasos

Executive Vice President & CFOAmneal Pharmaceuticals, Inc. (AMRX) · full profile →Form 4 · filed Aug 15, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.7M
Net Open-Market Flow
-$4.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 15, 2025Sell(S)219K$9.43$2.1M122K
Aug 14, 2025Sell(S)119K$9.30$1.1M341K
Aug 13, 2025Sell(S)161K$9.22$1.5M461K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001723128-25-000051) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.